NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Bajaj Consumer Care Ltd. core brand Almond Hair Oil has been under pressure due to headwinds of tepid consumer demand and downtrading to cheaper value-added hair oil segments.
With the expectations of improved consumer demand (rural recovery, moderating consumer inflation etc.) and management initiatives (improved value proposition, distribution efficiency, continued ad-spends), we expect improvement in volume growth.
Further, its non ADHO portfolio (~17% salience) is likely to continue its growth trajectory (+26% YoY in FY24) with continued scale-up of coconut portfolio (+36% in FY24) and almond drops extension (+16% YoY in FY24) in hair and skin care categories.
Operating margin is likely to be range bound (~16-18%) with continued investment towards ad-spends and slightly inferior mix of non-ADHO portfolio. At 17 times price earning FY26E, risk-reward is favorable. 'Buy'.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Buy, Sell Or Hold: Bajaj Finserv, Hinduja Global, Vedanta, Power Grid, Piramal Pharma — Ask Profit


'Add' Bajaj Electricals Shares Maintains PL Capital — Check Target Price


Association Of Healthcare Providers To Meet Bajaj Allianz Over Reimbursement Cost Impasse


Bajaj Consumer Care, Bata, IPCA Laboratories, Astral Q1 Results Today — Earnings Estimates
